| COMPANY |
agilon health, inc. |
| COURT |
United States District Court for the Western District of Texas |
| CASE NUMBER |
1:24-cv-00305 |
| JUDGE |
Honorable David A. Ezra |
| CLASS PERIOD |
November 4, 2022 through January 4, 2024 |
| SECURITY TYPE |
Common Stock |
Case Background:
This is a federal securities fraud class action lawsuit on behalf of a class of all persons and entities who purchased or otherwise acquired Agilon Health, Inc. (“Agilon”) common stock between November 4, 2022, and January 4, 2024, both dates inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants misled investors about Agilon's medical costs by: (1) touting the Company's purported visibility into utilization trends and medical costs; (2) failing to disclose increased medical costs that Agilon had incurred prior to and during the Class Period due to higher utilization of healthcare by MA patients; (3) falsely stating that its accounting reserves for higher-than-expected medical costs were adequate; (4) making false and misleading statements about the effectiveness of its business model; (5) issuing overly optimistic financial guidance; and (6) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.
Current Status of Case:
On August 15, 2025, the Court entered The Order granting in part and denying in part Defendants’ Motion to Dismiss the Amended Complaint. This action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.